BLFS Q3 2019 Earnings — BioLife Solutions, Inc. Revenue & Financial Results | Market Cap Arena

BLFSBioLife Solutions, Inc.

$890M

Q3 2019 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$7M+24.8% YoY

Gross Profit

$5M68.4% margin

Operating Income

-$597,000-9.0% margin

Net Income

$9M141.1% margin

EPS (Diluted)

$0.35

QoQ Revenue Growth

-1.4%

Cash Flow

Operating Cash Flow

$1M

Free Cash Flow

$1M

Stock-Based Comp.

$655,000

Balance Sheet

Total Assets

$84M

Total Liabilities

$7M

Stockholders' Equity

$77M

Cash & Equivalents

$21M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$5M	+24.8%
Gross Profit	$5M	$4M	+22.6%
Operating Income	-$597,000	$1M	-150.0%
Net Income	$9M	$1M	+656.9%

Revenue Segments

Media

$6M46%

Regenerative Medicine

$3M26%

Distribution Service

$3M20%

BioBanking

$345,0003%

Automated Thawing Products

$324,0002%

Drug Discovery

$225,0002%

Cold Chain Shipping

$211,0002%